Tahir Foundation and the Asia Pacific Leaders Malaria Alliance (APLMA)1 announced the launch of the M2030 Movement Program in Indonesia at the Ang Boen Ing Mayapada Hospital Auditorium, South Jakarta.
Started by APLMA in 2018, M2030 is a movement that brings together businesses, consumers, and healthcare organizations in one unique partnership. Corporate partners use the M2030 brand for awareness and fundraising campaigns to eradicate malaria. One hundred percent of the funds that have been collected in Indonesia will be used to assist the malaria elimination program in Indonesia.
Indonesia has made significant progress in the fight against malaria since 2010, with the number of cases dropping by 44 percent and the number of deaths by 80 percent. However, malaria is still a major public health concern in Indonesia’s eastern provinces, especially Papua. This explains why Tahir Foundation, in a partnership with the Asia Pacific Leaders Malaria Alliance (APLMA), recently launched M2030 in Indonesia. Started by the APLMA in 2018, M2030 is a movement that brings together businesses, consumers and health organizations in a unique joint effort. Corporate partners use the M2030 brand for awareness and fundraising campaigns to fight malaria. All of the funds raised in Indonesia will support malaria eradication programs in the country.
“Malaria is a preventable and treatable disease, and we know that it can be defeated. But the last mile is the hardest,” APLMA Chief Executive Officer Jeffery Smith said at the M2030 launch at the Mayapada Hospital. He went on to say, “the partnership with Tahir Foundation will take us one step closer to the goal of eliminating the disease in Indonesia by 2030.”
Tahir Foundation will spearhead M2030 in Indonesia by supporting the operations of M2030 financially as well as by bringing in new corporate partners. Tahir Foundation Cochairman Jonathan Tahir announced three pioneer M2030 partners in Indonesia at the event: JD.id, Mayapada Hospital and Sompo Insurance. These partners join a number of other M2030 businesses across Asia.
“Tahir Foundation is thrilled to lead the introduction of M2030 in Indonesia. This partnership will redefine how businesses can contribute to ending this disease [for the benefit of] in our country”, said Jonathan Tahir.
“M2030 is the best opportunity yet for the corporate sector to unite behind a single cause and defeat a disease older than humankind, for good,” added M2030 Cofounder Patrik Silborn. Despite recent gains in the fight against malaria, the progress is fragile. Following the earthquake in Lombok in 2018, malaria case numbers skyrocketed on the island. Natural disasters, a lack of resources and drug-resistant forms of malaria – prevalent in many other parts of South-East Asia – threaten to roll back years of progress. “As malaria is being pushed back, it risks becoming an invisible disease.
Now, more than ever, we need businesses and their leaders to get involved in the fight against malaria. M2030 partners like Tahir Foundation help put the spotlight on malaria, and together we can make history by finally eradicating malaria in Indonesia and across Asia”, said M2030 Chief Operating Officer Clint Coo. Tahir Foundation is a founding investor partner of M2030 and has supported the regional expansion in South-East Asia since 2018.
